TY  - JOUR
SN  - 2251-9939
AV  - public
TI  - Epidemiological, clinical and therapeutic aspects of
chronic lymphoid hemopathies observed at the
National Reference University Hospital Center (CHU-
RN) of N'Djamena
SP  - 18
Y1  - 2022/01/25/
PB  - Scienceline Publications, Ltd
N2  - Aim. This study aimed to determine the epidemiological, clinical, therapeutic profile of
chronic lymphoid hemopathies (CLH) and the viral factors linked to the genesis of HLCs at
the CHU-RN of Ndjamena in Chad. Methods. A descriptive cross-sectional study over two
and a half years, from October 2017 to March 2020 at the Hematology Unit of the National
Reference University Hospital Center (CHU-RN) of Ndjamena. Were included patients in
whom the diagnosis of chronic lymphoid hemopathy had been made. Results. Ninety-eight
(98) cases of hematological malignancies were recorded out of 531 hematological
consultations including 66 (12.43%) CLH and 67.35% of hematological malignancies with an
annual incidence of 26.4 cases. Chronic lymphocytic leukemia (CLL) was 56.06% (n=37)
followed by 25.76% (n=17) Malignant non-Hodgkin's lymphoma, 15.15% (n=10) Hodgkin's
lymphoma and 3.03 % (n=2) cutaneous lymphoma. A male predominance was observed for
all types of CLH. The most represented age groups were those of 51 to 60 years for CLL and
11 to 20 years for lymphomas. Conclusion: This study made it possible to have a better
epidemiological knowledge and the viral factors related to the genesis of CLH at the CHU-
RN of Ndjamena. It revealed difficulties in biological diagnosis and management, in
particular the initiation of chemotherapy.
UR  - https://jlsb.science-line.com/attachments/article/90/JLSB%2012(1)%2018-26,%202022.pdf
KW  - Chronic lymphoid
hemopathies
KW  - 
CHU-RN
KW  - 
Ndjamena
IS  - 1
EP  - 26
VL  - 12
ID  - eprints578
JF  - Journal of Life Science and Biomedicine
A1  - DJIMADOUM, Mbanga
A1  - NADLAOU, Bessimbaye
A1  - BLAISE, Lopiagoto Kemteud
A1  - OUCHEMI, Choua
A1  - MBAISSOUROUM, Mouanodji
ER  -